These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16995466)

  • 1. FK506 may reduce early liver injury following living related liver transplantation.
    Kato T; Sato Y; Kurosaki I; Yamamoto S; Hirano K; Nakatsuka H; Kobayashi T; Kameyama H; Watanabe T; Shirai Y; Hatakeyama K
    Hepatogastroenterology; 2006; 53(70):580-3. PubMed ID: 16995466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
    Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT
    Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
    Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
    Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum LECT 2 levels during the early period of liver regeneration after adult living related donor liver transplantation.
    Sato Y; Watanabe H; Kameyama H; Kobayashi T; Yamamoto S; Takeishi T; Hirano K; Oya H; Nakatsuka H; Watanabe T; Kokai H; Yamagoe S; Suzuki K; Oya K; Kojima K; Hatakeyama K
    Transplant Proc; 2004 Oct; 36(8):2357-8. PubMed ID: 15561248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury.
    Bogetti D; Sankary HN; Jarzembowski TM; Manzelli A; Knight PS; Thielke J; Chejfec G; Cotler S; Oberholzer J; Testa G; Benedetti E
    Clin Transplant; 2005 Aug; 19(4):507-11. PubMed ID: 16008596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial clinical effect of intraportal insulin administration on liver graft regeneration in adult patients underwent living donor right lobe liver transplantation.
    Xu MQ; Yan LN; Li B; Wen TF; Zeng Y; Zhao JC; Wang WT; Yang JY; Ma YK; Chen ZY; Zhang ZW
    Transplant Proc; 2009 Jun; 41(5):1698-702. PubMed ID: 19545710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of the bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation.
    Fukudo M; Yano I; Shinsako K; Katsura T; Takada Y; Uemoto S; Inui K
    J Clin Pharmacol; 2009 Jul; 49(7):789-97. PubMed ID: 19487492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo autoimmune hepatitis after living donor liver transplantation in a 25-day-old newborn baby: a case report.
    Oya H; Sato Y; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Hatakeyama K
    Transplant Proc; 2009; 41(1):433-4. PubMed ID: 19249573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation and fibrinolytic systems during liver regeneration in the early period after adult living related partial liver transplantation.
    Sato Y; Nakatsuka H; Yamamoto S; Oya H; Kobayashi T; Watanabe T; Kokai H; Kurosaki I; Shirai Y; Hatakeyama K
    Transplant Proc; 2008 Oct; 40(8):2501-2. PubMed ID: 18929779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation.
    St Peter SD; Post DJ; Rodriguez-Davalos MI; Douglas DD; Moss AA; Mulligan DC
    Liver Transpl; 2003 Feb; 9(2):144-9. PubMed ID: 12548508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of L-arginine against ischemia-reperfusion injury in non-heart beating rat liver graft.
    Gong J; Lao XJ; Zhang SJ; Chen S
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):481-4. PubMed ID: 18842493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria after living donor liver transplantation: report of two cases.
    Pandey D; Lee KH; Wong SY; Tan KC
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):210-3. PubMed ID: 18397860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spleen volume and platelet count changes among donors after living donor liver transplantation.
    Chen TY; Chen CL; Huang TL; Tsang LL; Wang CC; Liu YW; Yang CC; Concejero AM; Cheng YF
    Hepatogastroenterology; 2008; 55(85):1211-5. PubMed ID: 18795659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of maintaining normal serum albumin level following living related liver transplantation: does serum albumin level affect the course? A pilot study.
    Mukhtar A; EL Masry A; Moniem AA; Metini M; Fayez A; Khater YH
    Transplant Proc; 2007 Dec; 39(10):3214-8. PubMed ID: 18089356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of living-related liver transplantation for progressive familial intrahepatic cholestasis.
    Cutillo L; Najimi M; Smets F; Janssen M; Reding R; de Ville de Goyet J; Sokal EM
    Pediatr Transplant; 2006 Aug; 10(5):570-4. PubMed ID: 16856993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft preconditioning with low-dose tacrolimus (FK506) and nitric oxide inhibitor aminoguanidine (AGH) reduces ischemia/reperfusion injury after liver transplantation in the rat.
    Hüser N; Doll D; Altomonte J; Werner M; Kriner M; Preissel A; Thorban S; Matevossian E
    Arch Pharm Res; 2009 Feb; 32(2):215-20. PubMed ID: 19280151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hyperbaric oxygen treatment on postoperative morbidity of left lobe donor in living donor adult liver transplantation.
    Suehiro T; Shimura T; Okamura K; Okada T; Okada K; Hashimoto S; Mochida Y; Kuwano H; Saitoh S; Gotoh F
    Hepatogastroenterology; 2008; 55(84):1014-9. PubMed ID: 18705320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of Radix salviae miltiorrhizae on reperfusion injury and hepatocyte apoptosis in donor liver after orthotopic liver transplantation in rats].
    Wang Y; Zhou J; Jiang XQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):870-3. PubMed ID: 18504224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety limit of the extent of hepatectomy for rats with moderately fatty liver: experimental study concerning living liver donor safety.
    Morioka D; Watanabe K; Makino H; Saito S; Ueda M; Kubota T; Sekido H; Matsuo K; Ichikawa Y; Endo I; Togo S; Shimada H
    J Gastroenterol Hepatol; 2006 Feb; 21(2):367-73. PubMed ID: 16509860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation.
    Parker BM; Cywinski JB; Alster JM; Irefin SA; Popovich M; Beven M; Fung JJ
    Liver Transpl; 2008 Jan; 14(1):46-52. PubMed ID: 18161838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.